Literature DB >> 9279523

Gestational thyrotoxicosis manifesting as wernicke encephalopathy: a case report.

F Otsuka1, K Tada, T Ogura, N Hayakawa, Y Mimura, T Yamauchi, N Inoue, H Makino, T Kudo.   

Abstract

The thyroid gland is physiologically stimulated in normal early pregnancy. This stimulated thyroid function is occasionally termed "gestational transient thyrotoxicosis". The cause of this thyrotoxicosis has been clarified to closely it associate with human chorionic gonadotropin (hCG). We encountered a pregnant patient with hyperemesis and thyrotoxicosis, who manifested symptoms of Wernicke encephalopathy. Although her serum hCG concentration transiently increased in accordance with the thyrotoxicosis, it was within normal limits for the gestational week. Both the thyrotoxicosis and a catabolic state due to the hyperemesis were thought to have induced a vitamin B1 deficiency, causing the Wernicke encephalopathy. This case suggests that pregnant patients with hyperemesis should undergo careful endocrinological and neurological evaluations.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9279523     DOI: 10.1507/endocrj.44.447

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Wernicke's encephalopathy secondary to gestational hyperthyroidism.

Authors:  Vishnu Vardhan Garla; Licy Yanes-Cardozo; Tauqeer Yousuf; Shema Ahmad
Journal:  BMJ Case Rep       Date:  2017-11-23

2.  Wernicke's encephalopathy following Hyperemesis gravidarum. A report of three cases.

Authors:  V K Kotha; A De Souza
Journal:  Neuroradiol J       Date:  2013-03-08

3.  Wernicke's Encephalopthy Associated with Hyperemesis Gravidarum - A Case Report.

Authors:  Wahinuddin Sulaiman; Azerin Othman; Monniaty Mohamad; Hj Rosemi Salleh; Lily Mushahar
Journal:  Malays J Med Sci       Date:  2002-07

4.  Thyrotoxicosis associated Wernicke's encephalopathy.

Authors:  James Bonucchi; Ihab Hassan; Bruno Policeni; Peter Kaboli
Journal:  J Gen Intern Med       Date:  2007-11-17       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.